| Literature DB >> 26215981 |
Nicolas De Schryver1, Xavier Wittebole2, Catherine Hubert3, Jean-François Gigot4, Pierre-François Laterre5, Diego Castanares-Zapatero6.
Abstract
BACKGROUND: Postoperative pancreatic fistula (POPF) is a major complication after pancreatic surgery and results from an impaired healing of the pancreatic enteric anastomosis. Whether perioperative hemodynamic fluid management aiming to provide an adequate tissue perfusion could influence the occurrence of POPF is unknown. Serum lactate level is a well-recognized marker of decreased tissue perfusion and is known to be associated with higher morbidity and mortality in various postoperative settings. We aimed to determine in a retrospective high-volume center's cohort whether postoperative hyperlactatemia could predict POPF occurrence.Entities:
Mesh:
Year: 2015 PMID: 26215981 PMCID: PMC4517345 DOI: 10.1186/s12871-015-0093-x
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Patients characteristics and preoperative data
| Patient characteristics | Overall ( | No fistula ( | Fistula ( | |
|---|---|---|---|---|
| Demographics | ||||
| agea | 65 (27–82) | 64 (27–82) | 65.5 (40–80) | 0.77 |
| maleb | 56 (59) | 38 (40) | 18 (19) | 0.55 |
| Body mass index (kg/m2)c | 25.4 (4.7) | 24.7 (3.9) | 27.5 (4.1) | 0.04 |
| Comorbidities | ||||
| hypertensionb | 19 (20.5 %) | 11 (12 %) | 8 (8.5 %) | 0.18 |
| diabetes mellitusb | 17 (18 %) | 12 (13 %) | 5 (5 %) | 0.97 |
| ischemic cardiopathyb | 15 (16 %) | 11 (12 %) | 4 (4 %) | 0.99 |
| Surgical procedures | ||||
| pancreaticoduodenectomyb | 77 (82 %) | 56 (60 %) | 21 (22 %) | 0.26 |
| distal pancreatectomyb | 17 (18 %) | 10 (11 %) | 7 (7 %) | 0.26 |
| Pathological diagnosis | ||||
| benign diseaseb | 16 (17 %) | 10 (11 %) | 6 (6 %) | 0.55 |
| malignant diseaseb | 78 (83 %) | 56 (60 %) | 22 (23 %) | 0.55 |
avalues expressed as median (range); p-value by Mann–Whitney U test
bvalues expressed as number and percentage; p-value by χ2 test or exact Fisher test
cvalues expressed as mean ± standard deviation; p-value by Student t test
Surgical complications
| Complicationa | |
|---|---|
| pancreatic fistula | 28 (29 %) |
| intraabdominal collections | 11 (12 %) |
| hemorrhage | 3 (3.2 %) |
| anastomotic failure | 2 (2.1 %) |
| wound infection | 3 (3.2 %) |
| bile leakage | 3 (3.2 %) |
| portal vein thrombosis | 4 (4.2 %) |
| otherb | 2 (2.1 %) |
aSome patients developed multiple complications
bOther complications included small bowel perforation (n =1) and mesenteric ischemia (n =1)
Postoperative data
| No Fistula ( | Fistula ( | ||
|---|---|---|---|
| Postoperative baseline lactate (mmol/L)a | 1.9 (1.8) | 2.1 (1.6) | 0.64 |
| 6 h postoperative lactate (mmol/L)a | 1.8 (1.3) | 2.8 (2.5) | 0.04 |
| 12 h postoperative lactate (mmol/L)a | 1.7 (1.1) | 1.8 (1.4) | 0.81 |
| Hyperlactatemia (blood lactate ≥ 2.5 mmol/L)b | 18 (27 %) | 17 (60 %) | 0.002 |
| Vasopressor useb | 8 (13 %) | 7 (25 %) | 0.13 |
| Cumulative norepinephrine dose (μg/kg)a | 57 (43) | 48 (12) | 0.18 |
| Fluid intake during first 24 h (mL/kg)a | 46.2 (34) | 48.1 (43) | 0.15 |
| Fluid balance during first 24 h (mL)a | 2160 (2000) | 2631 (2339) | 0.34 |
| Intraoperative fluid requirements (mL/kg)a | 52.6 (25) | 49 (22) | 0.39 |
| Red blood cells transfusions during first 24 h (mL)a | 164 (250) | 359 (530) | 0.027 |
| Hemoglobin after first 24 h (g/dL)c | 10.4 ± 1.8 | 10.8 | 0.35 |
| APACHE II scorea | 12 (6) | 12.5 (8) | 0.98 |
| Duration of operation (minutes)c | 356 ± 96 | 316 ± 94 | 0.91 |
adata are shown as median (interquartile range); p-value by Mann–Whitney U test
bdata are shown as number (percentage); p-value by χ2 test or exact Fisher test
cdata are shown as mean ± standard deviation; p-value by Student t test
Risk factors associated with postoperative pancreatic fistula following pancreaticoduodenectomy
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Odds ratio (95 % CI) | Odds ratio (95 % CI) | |||
| Demographics | ||||
| Body mass index | 1.15 (1.10–1.27) | 0.015* | 1.11 (0.99–1.25) | 0.085 |
| Ischemic cardiopathy | 1.18 (0.32–4.32) | 0.79 | ||
| Post-operative variables | ||||
| Hyperlactatemia | 4.36 (1.70–11.15) | 0.002* | 3.58 (1.22–10.48) | 0.020* |
| RBC transfusions | 1.23 (1.05–1.45) | 0.008* | 1.24 (1.03–1.49) | 0.022* |
| Hemoglobin (24 h) | 1.13 (0.87–1.47) | 0.35 | ||
| Vasopressor use | 4.10 (1.14–13.97) | 0.003* | 2.10 (0.47–9.28) | 0.33 |
| Fluid intake (24 h) | 1.01 (0.99–1.03) | 0.12 | ||
| Fluid balance (24 h) | 1.19 (0.61–2.33) | 0.59 | ||
*denotes p < 0.05